1st Quarter - Amendment
XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
Income
—
Expenses
$120,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2010 | $110,000 | Replaced |
| 1st Quarter - Amendment (this page) | Oct 19, 2010 | $120,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Issues relating to biodefense and national security strategy, specifically including Anti-Botulinum toxin medical countermeasures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
| PATRICK JEROME SCANNON | — |
Budget/Appropriations BUD
FY2011 defense appropriations, provisions relating to biodefense and anti-botulinum toxin medical countermeasures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
| PATRICK JEROME SCANNON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.